Akums Drugs and Pharmaceuticals IPO vs Ceigall India IPO

Comparision between Akums Drugs and Pharmaceuticals IPO and Ceigall India IPO.

IPO Details

Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Ceigall India IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Akums Drugs and Pharmaceuticals IPO	Ceigall India IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited	ICICI Securities Limited Iifl Securities Ltd Jm Financial Limited
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Ceigall India IPO is up to ₹1,252.66 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is and of Ceigall India IPO is .

	Akums Drugs and Pharmaceuticals IPO	Ceigall India IPO
Face Value	₹2 per share	₹5 per share
Issue Price (Lower)	₹646.00 per share	₹380.00 per share
Issue Price (Upper)	₹679.00 per share	₹401.00 per share
Issue Price (Final)
Discount (Retail)
Discount (Employee)	₹64.00 per share	₹38.00 per share
Market Lot Size	22 shares
Fresh Issue Size	1,00,14,727 shares	1,70,63,640 shares
Fresh Issue Size (Amount)	up to ₹680.00 Cr	up to ₹684.25 Cr
OFS Issue Size	1,73,30,435 shares	1,41,74,840 shares
OFS Issue Size (Amount)	up to ₹1,176.74 Cr	up to ₹568.41 Cr
Issue Size Total	2,73,45,162 shares	3,12,38,480 shares
Issue Size Total (Amount)	up to ₹1,856.74 Cr	up to ₹1,252.66 Cr

IPO Timetable

Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Ceigall India IPO opens on Aug 01, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Ceigall India IPO is Aug 01, 2024, and Aug 05, 2024, respectively.

	Akums Drugs and Pharmaceuticals IPO	Ceigall India IPO
Anchor Bid Date	Jul 29, 2024	Jul 31, 2024
Issue Open	Jul 30, 2024	Aug 01, 2024
Issue Close	Aug 01, 2024	Aug 05, 2024
Basis Of Allotment (Tentative)	Aug 02, 2024	Aug 06, 2024
Initiation of Refunds (Tentative)	Aug 05, 2024	Aug 07, 2024
Credit of Share (Tentative)	Aug 05, 2024	Aug 07, 2024
Listing date (Tentative)	Aug 06, 2024	Aug 08, 2024
Anchor Lockin End date 1	Sep 01, 2024	Sep 05, 2024
Anchor Lockin End date 2	Oct 31, 2024	Nov 04, 2024

Financials

Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Ceigall India IPO P/E ratio of 20.67.

Akums Drugs and Pharmaceuticals IPO

Ceigall India IPO

Financial

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	3,516.37	3,266.53	3,069.05
Revenue	4,212.21	3,700.93	3,694.52
Profit After Tax	0.79	97.82	-250.87
Net Worth	709.50	717.19	621.98
Reserves and Surplus	861.01	868.70	787.79
Total Borrowing	491.56	536.97	357.95
Amount in ₹ Crore

Ceigall India Limited Financial Information (Restated Consolidated)

Ceigall India Limited's revenue increased by 46.92% and profit after tax (PAT) rose by 81.81% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	2,592.19	1,827.82	959.14
Revenue	3,066.19	2,087.04	1,146.50
Profit After Tax	304.91	167.70	126.43
Net Worth	906.41	593.06	431.25
Total Borrowing	1,811.02	1,252.58	652.12
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

84.94%

99.99%

Promoter Shareholding (Post-Issue)

P/E Ratio

20.67

Market Cap

₹6985.41 Cr.

ROE

0.11%%

33.57%%

ROCE

3.37%%

31.98%%

Debt/Equity

0.69

1.17

EPS

₹19.40

RoNW

-0.57%

33.57%%

Shares Offered

In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered while in Ceigall India IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Akums Drugs and Pharmaceuticals IPO and in Ceigall India IPO.

	Akums Drugs and Pharmaceuticals IPO	Ceigall India IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Akums Drugs and Pharmaceuticals IPO subscribed in total, whereas Ceigall India IPO subscribed .

	Akums Drugs and Pharmaceuticals IPO	Ceigall India IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)

Compare with others

Akums Drugs and Pharmaceuticals IPO	Ceigall India IPO
Ceigall India IPO	Akums Drugs and Pharmaceuticals IPO
Sanstar IPO	Sanstar IPO
Bansal Wire IPO	Bansal Wire IPO
Emcure Pharma IPO	Emcure Pharma IPO
OLA Electric IPO	OLA Electric IPO
Vraj Iron and Steel IPO

Comments

Add a public comment...